Reveal Pharma careers

Reveal has the potential to transform medical care for tens of millions of patients worldwide.
We are improving safety and deepening insight via precision MRI imaging.

Every person who has a contrast-enhanced MRI scan accumulates the heavy metal gadolinium in their brain, bone, and organs. The 40 million contrast enhanced MRIs performed each year also lead to 60 tons of toxic heavy metal entering the planet's water systems.

Reveal's first in class gadolinium-free contrast agent promises to be a direct substitute for current MRI contrast agents, producing equivalent images for the same indications, without the risks of gadolinium. Our patented technology forms a platform for precision imaging of fibrosis, thrombus, lymph nodes and more. This has the potential to be better than biopsy: granting repeatable three dimensional insight into disease. Applications include earlier readout of response to treatment, focusing clinical trials, and guiding targeted therapeutics and personalized medicine.

We will benefit you or someone who matters to you.

MassChallenge winner, HBS New Venture Competition awardee, two Fast Track SBIR grants (NCI and NIDDK), Massachusetts Life Sciences Center MassNextGen and Milestone Achievement Program awardee.